Filters
Hikma licenses VIBATIV® from Theravance
Press Release, Product
Hikma Pharmaceuticals for Investing in Healthcare at the World Economic Forum Dead Sea 2013
Press Release, Responsibility
Hikma Pharmaceuticals strongly objects to the use of its products in capital punishment
Press Release, Corporate
Hikma Pharmaceuticals launches its “Global Volunteering Campaign” with INJAZ’s “Young Volunteer Day”
Press Release, Responsibility
Hikma signs licensing and marketing agreement for Dance Biopharm’s inhaled insulin in MENA
Press Release, Corporate
Hikma provides update on its global Injectables business
Press Release, Corporate
Hikma signs agreement with Sinclair IS Pharma to license Flammacerium for the MENA region
Press Release, Product
Hikma Pharmaceuticals Preliminary Results
Press Release, Corporate
Notice of Prelim Results Announcement – Analyst Presentation
Press Release, Corporate
Hikma Pharmaceuticals Invites Top Organizations to 'Towards a Smoke-Free Environment' Session
Press Release, Responsibility
Hikma signs a licensing and distribution agreement with EffRx for its innovative osteoporosis medication
Press Release, Product
Hikma receives approval for Phenylephrine HCl Injection, USP
Press Release, Product
Hikma agrees to acquire the Egyptian Company for Pharmaceuticals & Chemical Industries, strengthening its position in th...
Press Release, Corporate
Hikma to present at the 31st Annual J.P. Morgan Healthcare Conference
Press Release, Corporate